drugset / Trial / NCT01495169
Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
NaSingle-groupOpen-labelTreatment
Summary
Tolerability, undertstanding of the action of the drug in the body, and understanding the effect of the drug in adolescent patients needing treatment with an antipsychotic medication
Timeline
- Start
- 2011-10
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iloperidone | Small molecule | 6 mg | Oral |
| Subject | Iloperidone | Small molecule | 12 mg | Oral |
| Subject | Iloperidone | Small molecule | 16 mg | Oral |
| Subject | Iloperidone | Small molecule | 20 mg | Oral |
| Subject | Iloperidone | Small molecule | 24 mg | Oral |
Indications
No indication recorded.